🟢 Context Therapeutics is trading 12.27% up in after-hours trading with no verified catalyst

Context Therapeutics is trading 12.27% higher at $0.27 after-hours, but available coverage has not established a specific reason for the rise.

• It closed at $0.24 on October 15; no October 15 after-hours company announcement surfaced.
• Earlier on October 15, Zacks added the company to its Strong Sell list, citing a 15% downward revision to current-year earnings consensus over 60 days. That news does not explain the later move.